Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies
Hemoglobinopathies are monogenic disorders affecting hemoglobin synthesis. Thalassemia and sickle cell disease (SCD) are considered the two major hemoglobinopathies. Thalassemia is a genetic disorder and one of the major hemoglobinopathies determined by an impairment of globin chain production, whic...
Main Authors: | Alessandra Di Paola, Maria Maddalena Marrapodi, Martina Di Martino, Giulia Giliberti, Giuseppe Di Feo, Deeksha Rana, Shakeel Ahmed, Maura Argenziano, Francesca Rossi, Domenico Roberti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2902 |
Similar Items
-
Epidemiological and molecular study of hemoglobinopathies in Mauritanian patients
by: Taher Mahmoud, et al.
Published: (2022-10-01) -
Iowa Newborn Screening Program Experience with Hemoglobinopathy Screening over the Last Two Decades and Its Increasing Global Relevance
by: Ryan Jilek, et al.
Published: (2024-03-01) -
Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan
by: Shaista Shabbir, et al.
Published: (2016-12-01) -
Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01) -
HLA haplotype frequencies and diversity in patients with hemoglobinopathies
by: Graziana M. Scigliuolo, et al.
Published: (2023-11-01)